Article

Aspheric IOL enhances mesopic contrast sensitivity

Munich, Germany-The aspheric Z9000 IOL (Tecnis, Pfizer) is associated with better mesopic contrast sensitivity relative to conventional IOLs, but does not maintain its superiority to spherical implants when testing is performed under mesopic conditions with glare, said Mike P. Holzer, MD, at the European Society of Cataract and Refractive Surgeons annual meeting.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
Related Content
(Image credit: AdobeStock/InkInvent) FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
August 13th 2025

FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 13th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 13th 2025

AI applications in cataract surgery: A surgeon’s perspective

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 13th 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

First FDA-approved treatment for MacTel performed
August 13th 2025

First FDA-approved treatment for MacTel performed

(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 13th 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

© 2025 MJH Life Sciences

All rights reserved.